Related Experiment Video
Updated: May 5, 2026

07:46
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
4.6K
Development of a virtual multidisciplinary meeting framework for less common cancers
Ian M Collins1,2, Jessica Freeman1, Justin Ludowyk3
1VCCC Alliance, Melbourne, Victoria, Australia.
Internal Medicine Journal
|February 3, 2025
Summary
Expertise for rare cancers is limited, especially regionally. A virtual multidisciplinary meeting (MDM) framework can improve access to specialized care for patients with less common cancers.
Area of Science:
- Oncology
- Medical Informatics
- Healthcare Management
Background:
- Less common cancers face significant expertise disparities compared to prevalent malignancies.
- Regional cancer patients often require travel to access specialized multidisciplinary team (MDT) opinions.
- Establishing virtual multidisciplinary meetings (MDMs) presents unique logistical and technical challenges.
Purpose of the Study:
- To outline a framework for developing virtual multidisciplinary meetings (MDMs) for less common cancers.
- To address the challenge of providing expert oncological care in underserved geographical areas.
- To facilitate improved patient outcomes through enhanced access to specialized cancer expertise.
Main Methods:
- Development of a structured framework for virtual MDM implementation.
- Identification of key components for successful virtual cancer MDT operation.
- Consideration of technological and collaborative strategies for remote MDM participation.
Main Results:
- A comprehensive framework for establishing virtual less common cancer MDMs has been developed.
- The framework addresses challenges in expertise access and geographical limitations.
- It provides a blueprint for creating sustainable virtual oncology MDTs.
Conclusions:
- Virtual MDMs offer a viable solution to improve expert care access for rare cancer patients.
- The developed framework can guide the establishment of effective virtual multidisciplinary teams.
- This approach has the potential to reduce disparities in cancer care delivery.
Related Concept Videos
Cancer
51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mouse Models of Cancer Study
4.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
4.7K
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K

